Literature DB >> 9308413

Bisphosphonates in the treatment of osteoporosis.

B J Dreyfuss, D S Rai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9308413      PMCID： PMC1304521     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  3 in total

Review 1.  Bone mass homeostasis and bisphosphonate action.

Authors:  G A Rodan
Journal:  Bone       Date:  1997-01       Impact factor: 4.398

2.  Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis.

Authors:  J R Tucci; R P Tonino; R D Emkey; C A Peverly; U Kher; A C Santora
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

3.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.